Display options
Cite
Lepcha A, Kurien M, Job A, et al. Chronic adenoid hypertrophy in children - is steroid nasal spray beneficial?. Indian J Otolaryngol Head Neck Surg. 2002;54(4):280-4doi: 10.1007/BF02993743.
Lepcha, A., Kurien, M., Job, A., Jeyaseelan, L., & Thomas, K. (2002). Chronic adenoid hypertrophy in children - is steroid nasal spray beneficial?. Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 54(4), 280-4. https://doi.org/10.1007/BF02993743
Lepcha, Anjali, et al. "Chronic adenoid hypertrophy in children - is steroid nasal spray beneficial?." Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India vol. 54,4 (2002): 280-4. doi: https://doi.org/10.1007/BF02993743
Lepcha A, Kurien M, Job A, Jeyaseelan L, Thomas K. Chronic adenoid hypertrophy in children - is steroid nasal spray beneficial?. Indian J Otolaryngol Head Neck Surg. 2002 Oct;54(4):280-4. doi: 10.1007/BF02993743. PMID: 23119911; PMCID: PMC3450470.
Copy Download .nbib Format: NLM
Share it on

Indian J Otolaryngol Head Neck Surg. 2002 Oct;54(4):280-4. doi: 10.1007/BF02993743.

Chronic adenoid hypertrophy in children - is steroid nasal spray beneficial?.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India

Anjali Lepcha, Mary Kurien, Anand Job, L Jeyaseelan, Kurien Thomas

Affiliations

  1. Department of Medicine & Clinical Epidemiology, Christian Medical College, Vellore, 632004 Tamilnadu, INDIA.

PMID: 23119911 PMCID: PMC3450470 DOI: 10.1007/BF02993743

Abstract

OBJECTIVE: [corrected] To the efficacy of naial btvlomethosone spry in the treatmrnl of chronic adenoid hypertrophy in children.

METHOD: .-1 randomized double-blind placebo-controlled study

SETTING: Tertiary academic referral center Patients: Aged 3-12 years diagnosed to have chronic nasal obstruction due to hypertrophied adenoids.

INTERVENTION: Intranasal beclomethasone at the dose of 200 microgramslday to one group and placebo to the other group in matched dispensers for 8 weeks.

OUTCOME MEASURES: Reduction of symptoms due to hypertrophied adenoids and the size of enlarged adenoids. Variables were noted at the beginning and end of the study for symptoms score severity. X-ray and flexible nasal endoscopie findings.

RESULTS: Analysis was done to find any significant improvement between the two groups. The Chisquare test was used to investigate the relationship between discrete variables. 26 children completed the study with 13 each in the drug and placebo group. There were 17 male and 9 female patients from 3 to 12 years of age. There was no significant difference in nasal obstruction, snoring or nasal discharge between the two groups. Comparison of x-rays and endoscopy also showed no significant difference between the 2 groups significant (P value =1.000 and P=0.0666 respectively).

CONCLUSION: This study indicates that intranasal beclomelhasone therapy is not useful in treatment of ehronic adenoid hypertrophy in the general pediatrie population.

Keywords: adenoid hypertrophy; beclomethosone nasal spray; children

References

  1. Clin Ther. 1997 Nov-Dec;19(6):1330-9 - PubMed
  2. Pediatrics. 1995 Mar;95(3):355-64 - PubMed
  3. Pediatr Clin North Am. 1989 Dec;36(6):1551-69 - PubMed
  4. J Allergy Clin Immunol. 1998 Feb;101(2 Pt 1):157-62 - PubMed
  5. Int Anesthesiol Clin. 1988 Spring;26(1):54-7 - PubMed
  6. Ann Allergy Asthma Immunol. 1998 Feb;80(2):198-206 - PubMed
  7. Clin Radiol. 1981 May;32(3):337-40 - PubMed
  8. Clin Otolaryngol Allied Sci. 1997 Apr;22(2):172-7 - PubMed

Publication Types